Pseudomonas aeruginosa is a common cause of infection in cystic fibrosis patients globally. However, the growing antibiotic resistance and the high cost of developing new antimicrobials emphasize the need for alternative approaches. While macrolide therapy has shown benefits, resistance to this treatment is on the rise, indicating the necessity for new agents. Plant-based compounds (PBCs), […]
Read More